Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany;Medizinische probleme und risiken bei der rabattvertragsgerechten umstellung von medikationen in Deutschland

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 27, 2008, Pages 1423-1428

  Pruszydlo, Autoren M G ^a   Quinzler, R ^a   Kaltschmidt, J ^a   Haefeli, W E ^a   Haefeli, Walter E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Computer assisted drug therapy; CPOE; Drug discount contracts; Drug economy; Drug prescriptions; Drug safety; Drug switching

Indexed keywords

ARTICLE; DRUG INFORMATION; DRUG SUBSTITUTION; GERMANY; LAW; PRESCRIPTION; RISK FACTOR; CONTRACT; COST CONTROL; DOSE RESPONSE; DRUG APPROVAL; DRUG CONTAMINATION; DRUG COST; DRUG DOSAGE FORM; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; DRUG PACKAGING; DRUG TOXICITY; ECONOMICS; EXPERT SYSTEM; HUMAN; LEGAL ASPECT; PATIENT EDUCATION; PHARMACOKINETICS; PUBLIC HEALTH;

GENERIC DRUG; PHARMACEUTICAL VEHICLES AND ADDITIVES;

CONTRACTS; COST SAVINGS; DOSAGE FORMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG APPROVAL; DRUG CONTAMINATION; DRUG COSTS; DRUG HYPERSENSITIVITY; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG PACKAGING; DRUG TOXICITY; DRUGS, GENERIC; EXPERT SYSTEMS; GERMANY; HUMANS; NATIONAL HEALTH PROGRAMS; PATIENT EDUCATION AS TOPIC; PHARMACEUTIC AIDS; RISK FACTORS; THERAPEUTIC EQUIVALENCY;

EID: 47149108318     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081094     Document Type: Article

References (16)

1. Atkin PA, Finnegan TP, Ogle SJ, Shenfield GM. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age Ageing 1994; 23: 113-116
2. Brasch J, De Groot AC. Konservierungsmittel.In: Fuchs T, Aberer W, (Hrsg). Kontaktekzem. 2. wesentlich überarbeitete Auflage. München-Deisenhofen: Dustri-Verlag Dr. Karl Feistle, 2007: 535-545
3. Burkhardt H, Gladisch R. Pharmakotherapie des alteren Menschen aus klinischer Sicht. Internist 2003; 44: 959-967
4. Choe HM, Stevenson JG, Streetman DS, Heisler M, Standiford CJ, Piette JD. Impact of patient financial incentives on participation and outcomes in a statin pill-splitting program. Am J Manag Care 2007; 13: 298-304
5. Kaltschmidt J, Gallin S, Haefeli WE. Essential functional requirements for an effective electronic drug information system in a hospital. Int J Clin Pharmacol Ther 2004; 42: 615 (Abstract)
6. Miller DP, Furberg CD, Small RH et al. Controlling prescription drug expenditures: a report of success. Am J Manag Care 2007; 13: 473-480
7. Overgaard ABA, Højsted J, Hansen R, Møller-Sonnergaard J, Christrup LL. Patients' evaluation of shape, size and colour of solid dosage forms. Pharm World Sci 2001; 23: 185-188
8. Quinzler R, Bertsche T, Szecsenyi J, Haefeli WE. Teilung von Tabletten: welchen Einfluss haben die Rabattverträge auf die Verordnungsqualität? Med Klin, 2008 (in press)
9. Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol 2006; 62: 1065-1073
10. Quinzler R, Haefeli WE. Tabletten teilen. Ther Umsch 2006; 63: 441-447
11. Quinzler R, Szecsenyi J, Haefeli WE. Tablet splitting: patients and physicians need better support (letter). Eur J Clin Pharmacol 2007; 63: 1203-1204
12. Qureshi NN, Hatcher J, Chaturvedi N, Jafar TH Hypertension Research Group. Effect of general practitioner education on adherence to antihypertensive drugs: cluster randomised controlled trial. BMJ 2007; 335: 1030
13. Rogkakou A, Guerra L, Scordamaglia A, Canonica GW, Passalacqua G. Severe skin reaction due to excipients of an oral iron treatment. Allergy 2007; 62: 334-335
14. Schäfer T, Böhler E, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy 2001; 56: 1192-1196
15. Senger C, Pruszydlo MG, Schmitt SPW, Seidling HM, Kaltschmidt J, Haefeli WE. Successful development of a comprehensive database model integrating data of clinical research and the current drug market for computerized decision support (Abstract). Basic Clin Pharmacol Toxicol 2007; 101: 387
16. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Generic substitution of antihypertensive drugs: Does it affect adherence? Ann Pharmacother 2006; 40: 15-20